Cargando…
Long-term use of ultra-low-dose mifepristone for uterine leiomyoma control and safety discussion: A case report
In recent years, many clinical trials have used low-dose mifepristone to control uterine fibroids, some of which have achieved good results. However, according to the classic concept, long-term use of mifepristone could induce malignant transformation of the endometrium, and the effect of ultra-low-...
Autores principales: | Zhou, Guangdi, Li, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803439/ https://www.ncbi.nlm.nih.gov/pubmed/36595976 http://dx.doi.org/10.1097/MD.0000000000032413 |
Ejemplares similares
-
The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017) -
Uterine leiomyoma with fumarate hydratase deficiency: A case report
por: Huang, Yan, et al.
Publicado: (2021) -
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial
por: Liu, Chongdong, et al.
Publicado: (2017) -
Association between uterine leiomyoma and metabolic syndrome in parous premenopausal women: A case–control study
por: Tak, Young Jin, et al.
Publicado: (2016) -
Uterine torsion with degeneration and infarction of giant leiomyoma in a postmenopausal woman: A case report
por: Ye, Zhongxue, et al.
Publicado: (2023)